Well, SP announced her rash decisions and it seems clear what direction the Sleep BU is headed towards. I would say it is the perfect time to run from this company.
Well, SP announced her rash decisions and it seems clear what direction the Sleep BU is headed towards. I would say it is the perfect time to run from this company.
More like firing off the minorities in the company (clearly), merging into one team while STILL not advancing clinically for the asset, and adding useless roles to the org. Sales may improve in the short run, but reps will likely start running in the new year as doctors will see that we still have no idea what our drug is and what the disease state actually is.
Well, SP announced her rash decisions and it seems clear what direction the Sleep BU is headed towards. I would say it is the perfect time to run from this company.
